首页 | 官方网站   微博 | 高级检索  
     

参麦注射液联合同步放化疗治疗中晚期食管癌的临床观察
引用本文:濮娟.参麦注射液联合同步放化疗治疗中晚期食管癌的临床观察[J].湖南中医药大学学报,2011,31(8):30-31,34.
作者姓名:濮娟
作者单位:江苏省涟水县人民医院放疗科,江苏淮安,223400
摘    要:目的评价参麦注射液联合同步放化疗治疗中晚期食管癌的近期疗效和放化疗不良反应。方法将94例中晚期食道癌患者随机分为对照组和试验组,2组均采用同步放化疗:放疗总量为60~66 Gy(6~7周),且在放疗d1、d29予以2次FP方案化疗。试验组在上述给药基础上再静脉注射参麦注射液60 ml,d1-14、d29-42。结果试验组的近期有效率为83.0%,对照组为72.3%,两组差异具有统计学意义(P<0.05)。试验组的Ⅲ/Ⅳ级消化道毒性反应、白细胞毒性反应发生率与对照组比较,均明显减轻(P<0.05)。结论参麦注射液能够有效提高中晚期食管癌同步放化疗的临床疗效,且能显著减少放化疗的不良反应。

关 键 词:参麦注射液  同步放化疗  中晚期食道癌  不良反应

A Clinical Study on the combination of Shenmai Injection and Concurrent Chemoradiotherapy for Advanced Esophageal Carcinoma
PU Juan.A Clinical Study on the combination of Shenmai Injection and Concurrent Chemoradiotherapy for Advanced Esophageal Carcinoma[J].Journal of Traditional Chinese Medicine University of Hunan,2011,31(8):30-31,34.
Authors:PU Juan
Affiliation:PU Juan(Department of Radiation,People’Hospital of Lianshui county,Jiangsu Province,Huaian,Jiangsu 223400,China)
Abstract:Objective To observe the short-term efficacy and adverse reactions of the combination of Shenmai Injection and concurrent chemoradiotherapy for advanced esophageal carcinoma.Methods A total of 94 patients with advanced esophageal carcinoma were randomly assigned to either trial group or control group,with 47 patients each.Both groups received the same concurrent radiochemotherapy,including radiotherapy at a dose of 60-66 Gy(6-7 weeks) plus FP chemotherapy on days 1 and 29 of radiotherapy.Meanwhile,the trial...
Keywords:Shenmai Injection  Concurrent chemoradiotherapy  Advanced esophageal carcinoma  Adverse reactions  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号